salivary gland neoplasm: ['Tumors of the SALIVARY GLANDS.']
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
606 |
4. Check minimum number of eventsNone |
606 |
5. Include endpointsNone |
606 |
6. Filter based on genotype QC (FinnGen only) |
587 |
Control definitions (FinnGen only)
Controls for this endpoint are individuals that are not cases.
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF2
- Parent code in ICD-10
- D33
- Name in latin
- Neoplasma benignum cerebri supratentoriale
Similar endpoints
↥List of similar endpoints to
Benign neoplasm: Brain, supratentorial
based on the number of shared cases.
Similar with more cases:
- Benign neoplasm of brain and other parts of central nervous system
- Benign neoplasms
- Neoplasms
- Any event in hilmo or specialist outpatient
- Any prescribed medicine buy
Similar with less cases:
None
Case counts by codes
↥
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 4145 | 2224 | 1899 |
| Only index persons | 3782 | 2059 | 1723 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.06 | 0.06 | 0.05 |
| Only index persons | 0.07 | 0.08 | 0.07 |
| Median age at first event (years) | |||
| Whole population | 49.48 | 51.35 | 47.25 |
| Only index persons | 48.74 | 50.53 | 46.61 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 587 | 339 | 248 |
| Unadjusted period prevalence (%) | 0.12 | 0.12 | 0.11 |
| Median age at first event (years) | 50.38 | 46.72 | 55.38 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
CodeWAS
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 606
- Matched controls
- 6060
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
AAB00
NOMESCO Finland
Extirpation of intracranial lesion
150.1
307.7
238
26
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
23.4
307.7
320
277
D33.00
ICD-10 Finland
Medial pilosytic astrocytoma of the cerebrum
+∞
218.3
196
*
AAB10
NOMESCO Finland
Partial excision of intracranial lesion
79.7
206.1
111
17
D32.00
ICD-10 Finland
Benign tumor of the meninges on the outer surface of the cerebrum
62.0
160.3
90
17
D33.07
ICD-10 Finland
Colloid coast in cerebral ventricle
+∞
157.3
144
*
111
Kela drug reimbursment
Epilepsy and comparable convulsive disorders
14.4
155.9
159
146
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
22.8
152.0
117
63
N03AF02
ATC
oxcarbazepine; oral
14.5
112.7
109
90
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
8.3
111.8
178
289
D33.02
ICD-10 Finland
Another benign medial tumor of the cerebrum
+∞
109.8
102
*
AA1CM
NOMESCO Finland
Extensive MRI examination of brain with 3 Tesla magnet
21.3
103.0
80
43
N03AX14
ATC
levetiracetam; systemic
15.9
98.4
89
65
G40.29
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
18.7
88.9
73
44
9530/0-C70.0
ICD-O-3
Meningioma, NOS, of cerebral meninges
42.2
88.8
54
14
182
Kela drug reimbursment
Brivaracetam, eslikarbazepin, gabapentin, lacosamide, levetiracetam, perampanel, pregabalin, tiagabin and zonisamide
16.5
87.6
77
53
D32.02
ICD-10 Finland
Benign tumor of the meninges at the base of the brain
30.4
86.6
58
21
D33.08
ICD-10 Finland
Another benign tumor of the cerebral ventricle
+∞
83.3
78
*
G40.22
ICD-10 Finland
Complex partial epileptic seizure with secondary generalization
17.5
82.4
70
45
D33.05
ICD-10 Finland
Other lateral benign tumor in temporal lobe
+∞
72.4
68
*
AA1AD
NOMESCO Finland
CT of head and brain
4.4
69.2
272
949
ZXC95
NOMESCO Finland
Use of surgical navigator
20.6
68.2
53
28
G40.9
ICD-10 Finland
Epilepsy, unspecified
9.3
57.3
73
88
G40.20
ICD-10 Finland
Complex partial seizures with only alteration of consciousness
20.0
54.9
43
23
D33.30
ICD-10 Finland
Acoustic neuroma
82.8
54.1
60
8
D43.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, supratentorial
81.3
53.1
59
8
XA800
NOMESCO Finland
Neuropsychological investigation
7.4
52.8
83
128
AA1AG
NOMESCO Finland
Short MRI examination of brain with median intensity magnet
14.8
52.5
48
35
H53.4
ICD-10 Finland
Visual field defects
13.0
47.6
47
39
XCK00
NOMESCO Finland
Perimetry
6.2
46.6
87
160
AAF05
NOMESCO Finland
Ventriculoperitoneal shunt
20.1
46.1
36
19
R56.8
ICD-10 Finland
Other and unspecified convulsions
6.2
45.6
85
156
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
3.9
44.8
168
545
D33.0
ICD-10 Finland
Benign neoplasm: Brain, supratentorial
+∞
44.3
42
*
G91.1
ICD-10 Finland
Obstructive hydrocephalus
75.9
43.7
49
7
G40.12
ICD-10 Finland
Simple partial seizures with secondary generalization
16.1
40.3
35
23
N03AG01
ATC
valproic acid; systemic, rectal
5.1
36.2
84
187
183
Kela drug reimbursment
Lamotrigin and topiramate
12.5
31.9
32
27
AA1CD
NOMESCO Finland
Very extensive CT of head and brain
10.9
31.8
35
34
D33.04
ICD-10 Finland
Temporal lobe
+∞
31.5
30
*
H02AB02
ATC
dexamethasone; systemic
3.7
30.3
113
358
N03AB02
ATC
phenytoin; systemic
9.9
29.1
34
36
R51.80
ICD-10 Finland
Headache
3.0
28.4
159
643
N03AF01
ATC
carbamazepine; oral, rectal
4.9
27.5
64
142
D32.9
ICD-10 Finland
Benign neoplasm: Meninges, unspecified
56.2
27.4
32
6
D33.03
ICD-10 Finland
Pilosytic lateral astrocytoma of the strobe brain
+∞
27.3
26
*
D33.01
ICD-10 Finland
Medial ganglion glioma of the cerebrum
+∞
26.2
25
*
WX882
NOMESCO Finland
High dependency care
6.8
26.0
42
66
D33.9
ICD-10 Finland
Benign neoplasm: Central nervous system, unspecified
141.0
25.8
27
*
H02AB09
ATC
hydrocortisone; systemic
7.0
25.4
40
61
Z01.0
ICD-10 Finland
Examination of eyes and vision
2.8
24.8
156
667
D33.2
ICD-10 Finland
Benign neoplasm: Brain, unspecified
65.0
22.0
25
*
N03AX18
ATC
lacosamide; systemic
21.0
21.9
32
16
D32.01
ICD-10 Finland
Benign tumor of meninges on interhemispheric surface
29.3
21.1
28
10
D33.06
ICD-10 Finland
Plexus papilloma of the ventricle of the brain
+∞
19.9
19
*
ZXE20
NOMESCO Finland
More than three and less than five hours
2.8
19.4
112
454
D32.0
ICD-10 Finland
Benign neoplasm: Cerebral meninges
47.7
19.3
23
5
G93.0
ICD-10 Finland
Cerebral cysts
35.6
19.0
24
7
L01AX03
ATC
temozolomide; systemic
21.7
18.8
27
13
WX408
NOMESCO Finland
General anesthesy, balanced
2.3
18.7
189
995
D33.7
ICD-10 Finland
Benign neoplasm: Other specified parts of central nervous system
195.8
18.6
19
*
D35.2
ICD-10 Finland
Benign neoplasm: Pituitary gland
27.7
17.9
24
9
Z2445
NOMESCO Finland
Psychologist
3.9
17.3
53
145
AA1DM
NOMESCO Finland
Very extensive MRI examination of brain with 3 Tesla magnet
15.4
17.3
28
19
AA1BD
NOMESCO Finland
Extensive CT of head and brain
6.0
17.3
31
54
E23.00
ICD-10 Finland
Panhypopituitarism
51.6
17.1
20
*
AAF99
NOMESCO Finland
Other shunt operation on ventricle of brain or intracerebral cyst
92.7
16.6
18
*
R41.8
ICD-10 Finland
Other and unspecified symptoms and signs involving cognitive functions and awareness
3.0
16.3
77
278
C71.11
ICD-10 Finland
Malignant tumor of frontal lobe grade II glioma
61.7
15.8
18
*
9560/0-C72.4
ICD-O-3
Schwannoma, NOS, of acoustic nerve
87.4
15.6
17
*
AAF25
NOMESCO Finland
Removal of shunt of ventricle of brain
87.4
15.6
17
*
CK2X4
NOMESCO Finland
Optical coherence tomography (OCT) of ocular fundus
2.9
15.6
77
285
9530/0-C70.9
ICD-O-3
Meningioma, NOS, of meninges, NOS
164.1
15.5
16
*
G40.19
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
18.3
15.3
23
13
R90.8
ICD-10 Finland
Other abnormal findings on diagnostic imaging of central nervous system
12.9
15.0
26
21
2152
FHL
Extraction, big brain
153.6
14.5
15
*
Z50.8
ICD-10 Finland
Care involving use of other rehabilitation procedures
3.1
14.4
64
223
C71.10
ICD-10 Finland
Malignant tumor in frontal lobe without histology
27.9
14.3
19
7
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
3.4
14.0
53
167
C71.90
ICD-10 Finland
Malignant tumor in unspecified localization in the brain without histology
54.7
13.9
16
*
C71.20
ICD-10 Finland
Malignant tumor in temporal lobe without histology
54.7
13.9
16
*
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
2.9
13.9
70
262
ZXD10
NOMESCO Finland
Scheduled procedure
2.0
13.7
241
1531
N76
ICPC
Neoplasm nervous system unspecified
76.9
13.6
15
*
H53.2
ICD-10 Finland
Diplopia
4.5
13.5
33
76
N88
ICPC
Epilepsy
18.8
13.4
20
11
R42
ICD-10 Finland
Dizziness and giddiness
2.1
13.4
147
787
101
Kela drug reimbursment
Anterior pituitary hypofunction
15.5
13.2
21
14
G40.10
ICD-10 Finland
Simple partial seizures
17.2
13.1
20
12
H47.2
ICD-10 Finland
Optic atrophy
29.1
13.0
17
6
ZXC40
NOMESCO Finland
Use of ultrasound
12.6
12.7
22
18
D43.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Central nervous system, unspecified
71.4
12.6
14
*
D32.03
ICD-10 Finland
Benign meningioma in ventricles
71.4
12.6
14
*
9505/1-C71.9
ICD-O-3
Ganglioglioma, NOS, of brain, NOS
+∞
12.5
12
*
AWB00
NOMESCO Finland
Reoperation for superficial infection in surgery of the nervous system
132.6
12.5
13
*
DE2CG
NOMESCO Finland
Acoustic channel extensive MRI examination with high intensity magnet
11.4
12.1
22
20
N05BA09
ATC
clobazam; oral
12.0
11.9
21
18
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.5
11.9
83
366
ZXE10
NOMESCO Finland
More than one and less than three hours
1.9
11.9
221
1417
AAG50
NOMESCO Finland
Stereotactic intracranial radiotherapy
16.8
11.7
18
11
Z3226
NOMESCO Finland
Physiotherapist
2.1
11.7
125
659
C71.29
ICD-10 Finland
Malignant tumor in temporal lobe other or unspecified histology
+∞
11.5
11
*
CBK11
NOMESCO Finland
Operation for lagophtalmus with implant
+∞
11.5
11
*
D33.3
ICD-10 Finland
Benign neoplasm: Cranial nerves
+∞
11.5
11
*
9421/1-C71.9
ICD-O-3
Pilocytic astrocytoma of brain, NOS
+∞
11.5
11
*
D33.37
ICD-10 Finland
Another benign tumor of the cranial nerves
+∞
11.5
11
*
ABB00
NOMESCO Finland
Excision of lesion of spinal canal
122.2
11.5
12
*
AAG00
NOMESCO Finland
Stereotactic intracranial biopsy
35.8
11.3
14
*
TAB00
NOMESCO Finland
Lumbar puncture
3.2
11.3
45
147
AAF00
NOMESCO Finland
Ventriculostomy
17.5
11.2
17
10
Z3229
NOMESCO Finland
Other healthcare associate professional
2.7
11.2
64
255
G40.21
ICD-10 Finland
Partial epileptic seizure with cloudiness and automatism
25.6
11.2
15
6
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.2
10.9
104
523
CS424
NOMESCO Finland
Visual field testing with Goldmann perimetry
10.8
10.8
20
19
ZXC86
NOMESCO Finland
Use of endoscopic device
28.6
10.8
14
5
N06CA01
ATC
amitriptyline and psycholeptics; systemic
2.5
10.8
70
298
R4150
NOMESCO Finland
Neuropsychological rehabilitation
10.3
10.6
20
20
N03AX09
ATC
lamotrigine; oral
3.1
10.5
45
153
N75
ICPC
Benign neoplasm nervous system
111.9
10.4
11
*
D33.39
ICD-10 Finland
Benign tumor of the cranial nerves UNS
111.9
10.4
11
*
C71.21
ICD-10 Finland
Malignant tumor of temporal lobe grade II glioma
111.9
10.4
11
*
2250A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Brain
+∞
10.4
10
*
D33.10
ICD-10 Finland
Benign pilosytic astrocytoma of brain stem
+∞
10.4
10
*
C71.50
ICD-10 Finland
Malignant tumor of cerebral ventricle without histology
+∞
10.4
10
*
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
10.9
10.3
19
18
G91.0
ICD-10 Finland
Communicating hydrocephalus
19.2
10.3
15
8
AA1BM
NOMESCO Finland
MRI examination of brain with 3 Tesla magnet
7.7
10.3
23
31
CS444
NOMESCO Finland
Visual field testing with Octopus automated perimetry
3.7
10.1
32
90
C71.00
ICD-10 Finland
Malignant tumor of the cerebrum except lobes and ventricles without histology
40.8
10.0
12
*
H49.0
ICD-10 Finland
Third [oculomotor] nerve palsy
26.5
9.8
13
5
G91.9
ICD-10 Finland
Hydrocephalus, unspecified
20.4
9.8
14
7
R51
ICD-10 Finland
Headache
2.9
9.5
44
157
D43.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, infratentorial
101.6
9.4
10
*
H02.2
ICD-10 Finland
Lagophthalmos
30.5
9.4
12
*
9413/0-C71.9
ICD-O-3
Dysembryoplastic neuroepithelial tumor of brain, NOS
+∞
9.4
9
*
2252A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cerebral meninges
+∞
9.4
9
*
130
Kela drug reimbursment
Malignant tumour
2.5
9.3
58
242
Z3231
NOMESCO Finland
Registered nurse
1.8
9.2
173
1096
R4110
NOMESCO Finland
Physiotherapy
1.8
9.2
168
1056
R1230
NOMESCO Finland
Neuropsychological evaluation of need and possibilities to rehabilitation
7.9
9.2
20
26
WF099
NOMESCO Finland
Other radiotherapy
15.9
9.1
14
9
D43.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Brain, unspecified
37.3
9.0
11
*
D32.04
ICD-10 Finland
Secondary or multiple benign tumor of the meninges above the exam
37.3
9.0
11
*
C71.12
ICD-10 Finland
Malignant tumor of frontal lobe grade III glioma
37.3
9.0
11
*
Q28.3
ICD-10 Finland
Other malformations of cerebral vessels
24.4
8.9
12
5
G40.2
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures
10.9
8.8
16
15
F32.9
ICD-10 Finland
Depressive episode, unspecified
2.1
8.7
91
474
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.1
8.6
36
121
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
2.0
8.6
97
519
G51.0
ICD-10 Finland
Bell palsy
4.2
8.6
23
57
G40
ICD-10 Finland
Epilepsy
7.5
8.5
19
26
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.9
8.4
128
759
N05AX08
ATC
risperidone; systemic
2.4
8.4
60
267
D33.11
ICD-10 Finland
Brain stem
+∞
8.3
8
*
AAJ20
NOMESCO Finland
Excision of epileptic focus
+∞
8.3
8
*
G40.11
ICD-10 Finland
Simple partial epileptic seizure that develops into a complex partial seizure
14.7
8.2
13
9
WF002
NOMESCO Finland
Radical radiotherapy
2.9
8.2
39
141
CS434
NOMESCO Finland
Visual field testing with Humphrey automated perimetry
4.5
8.2
20
46
XKD00
NOMESCO Finland
Uroflowmetry
2.1
8.2
84
434
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
2.0
8.1
93
501
WX110
NOMESCO Finland
Infiltration anesthesia
1.7
7.9
429
3562
D18.0
ICD-10 Finland
Haemangioma, any site
4.1
7.9
21
52
H49.2
ICD-10 Finland
Sixth [abducent] nerve palsy
11.0
7.8
14
13
G41.9
ICD-10 Finland
Status epilepticus, unspecified
18.6
7.6
11
6
AAF20
NOMESCO Finland
Revision of shunt of ventricle of brain
18.6
7.6
11
6
N03AX11
ATC
topiramate; oral
3.6
7.6
25
72
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
10.2
7.6
14
14
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.6
7.5
255
1879
CS5Z4
NOMESCO Finland
Specialised imaging for glaucoma
4.5
7.5
18
41
D32.05
ICD-10 Finland
Cerebral meninges
81.1
7.4
8
*
XCW99
NOMESCO Finland
Other investigative procedure of eye
2.2
7.4
67
329
H01AC01
ATC
somatropin; parenteral
13.6
7.4
12
9
D32.06
ICD-10 Finland
Benign tumor of the meninges os petrosum or clivus area
+∞
7.3
7
*
D42.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Cerebral meninges
+∞
7.3
7
*
D32.1
ICD-10 Finland
Benign neoplasm: Spinal meninges
+∞
7.3
7
*
Q85.01
ICD-10 Finland
Neurofibromatosis, type 2
+∞
7.3
7
*
9505/1-C71.2
ICD-O-3
Ganglioglioma, NOS, of temporal lobe
+∞
7.3
7
*
G40.09
ICD-10 Finland
Other or unspecified partial (focal) idiopathic epilepsy or epileptic syndrome with local onset
16.0
7.2
11
7
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
7.2
133
832
R55
ICD-10 Finland
Syncope and collapse
2.1
6.9
68
346
D35.30
ICD-10 Finland
Craniopharyngoma
40.5
6.8
8
*
102
Kela drug reimbursment
Diabetes insipidus
22.8
6.7
9
*
WX872
NOMESCO Finland
Intensive care
2.8
6.6
32
117
ZYC01
NOMESCO Finland
Remote contact by phone
2.5
6.6
43
183
G40.39
ICD-10 Finland
Other or unspecified generalized epileptic syndromes with atonic, clonic, myoclonic or tonic-clonic seizures
12.4
6.6
11
9
ZZC00
NOMESCO Finland
Graft of fascia
70.6
6.4
7
*
E22.80
ICD-10 Finland
Central precocious puberty
70.6
6.4
7
*
D33.40
ICD-10 Finland
Benign glioma of the spinal cord (grade I)
70.6
6.4
7
*
T85.0
ICD-10 Finland
Mechanical complication of ventricular intracranial (communicating) shunt
70.6
6.4
7
*
N03AX23
ATC
brivaracetam; systemic
14.5
6.4
10
7
A02BC02
ATC
pantoprazole; systemic
1.6
6.4
376
3100
CS494
NOMESCO Finland
Other visual field testing
3.5
6.3
21
61
G40.1
ICD-10 Finland
Localization-related (focal)(partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures
18.2
6.3
9
5
N03AX15
ATC
zonisamide; oral
18.2
6.3
9
5
E22.1
ICD-10 Finland
Hyperprolactinaemia
18.2
6.3
9
5
2159
FHL
Other measure in this category
+∞
6.3
6
*
D35.59
ICD-10 Finland
Other paragangliom
+∞
6.3
6
*
AAA10
NOMESCO Finland
Biopsy through craniotomy
+∞
6.3
6
*
C71.22
ICD-10 Finland
Malignant tumor of temporal lobe grade III glioma
+∞
6.3
6
*
AAE32
NOMESCO Finland
Translabyrinthine excision acoustic neurinome
+∞
6.3
6
*
D44.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Pineal gland
+∞
6.3
6
*
2251A
ICD-9 Finland
Benign neoplasm of brain and other parts of nervous system, Cranial nerves
+∞
6.3
6
*
C71.40
ICD-10 Finland
Malignant tumor of the occipital lobe without histology
+∞
6.3
6
*
C71.59
ICD-10 Finland
Malignant tumor of cerebral ventricle other or unspecified histology
+∞
6.3
6
*
301
Kela drug reimbursment
Growth hormone
27.0
6.2
8
*
D32.07
ICD-10 Finland
Secondary or multiple benign tumor of the meninges below the exam
27.0
6.2
8
*
AA7AA
NOMESCO Finland
Liquor cerebri shunt X-ray examinatin without contrast
27.0
6.2
8
*
N29
ICPC
Neurological sympt/complt other
5.1
6.2
18
36
WZC00
NOMESCO Finland
Treatment plan or consultation
1.6
6.2
208
1513
G40.89
ICD-10 Finland
Other epilepsy
12.7
6.1
10
8
YA1VG
NOMESCO Finland
MRI examination of head and neck with high intesity magnet for dose design of radiotherapy
12.7
6.1
10
8
ZX050
NOMESCO Finland
Stereotactic radiotherapy
8.7
6.1
12
14
G44.2
ICD-10 Finland
Tension-type headache
1.8
6.1
89
519
Z2446
NOMESCO Finland
Social worker
2.2
6.0
50
237
ZY010
NOMESCO Finland
Hospital outpatient
2.4
6.0
40
172
SPAT1360
SPAT
Extensive global examination
2.4
6.0
40
172
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
6.0
120
765
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
48
39
13.28
49.24
1.3
1.6
—
—
—
0
0
149
491
3.70
38.26
6.7
8.4
1.36
1.25
mmol/l
0.16
108
401
148
492
3.66
37.44
6.8
8.3
16.05
12.64
kpa
6.25
138
476
148
492
3.66
37.44
6.8
8.3
5.07
5.14
kpa
0.44
139
473
40
41
10.37
35.11
2.5
1.2
—
—
—
0
0
367
2269
2.57
27.68
7.6
6.8
1.21
1.21
mmol/l
1.60
345
1930
342
2058
2.52
27.16
7.0
6.1
1.20
1.22
mmol/l
3.68
325
1880
55
113
5.25
25.82
2.2
1.6
15.54
11.79
e6/l
0.15
46
90
55
113
5.25
25.82
2.3
1.7
2593.87
142.95
e6/l
0.80
47
93
52
113
4.94
22.86
2.0
1.6
3.53
3.69
mmol/l
0.41
47
104
238
1368
2.22
19.11
2.6
2.0
269.27
234.92
u/l
0.12
230
1289
389
2811
2.07
16.06
6.2
4.8
6.38
6.62
mmol/l
1.72
373
2602
107
467
2.57
15.80
3.4
1.8
303.03
373.09
nmol/l
3.17
98
426
27
23
12.23
15.19
1.8
1.3
—
—
—
0
0
115
554
2.33
13.57
7.0
6.5
—
—
—
0
0
31
70
4.61
12.98
5.1
4.7
373.72
383.19
umol/l
0.12
25
62
133
703
2.14
12.44
2.3
2.1
28.85
29.73
s
0.58
133
687
196
1201
1.93
12.13
3.7
3.8
94.38
91.74
%
0.90
190
1178
312
2266
1.78
10.82
2.5
2.5
—
—
—
0
0
185
1151
1.87
10.71
2.2
2.2
—
—
—
0
0
22
53
4.27
8.52
1.0
1.1
—
—
—
0
0
20
31
6.63
8.24
1.1
1.0
—
—
—
0
0
22
55
4.11
8.13
1.0
1.1
—
—
—
0
0
123
746
1.81
7.43
1.8
1.9
—
—
—
0
0
280
2117
1.60
7.34
10.3
12.1
1.20
1.21
inr
0.09
70
650
257
1932
1.57
6.74
4.8
4.6
35.63
36.07
g/l
0.61
241
1808
354
2868
1.56
6.62
10.4
9.2
4.26
4.05
e9/l
0.81
306
2523
443
3783
1.64
6.60
4.9
3.9
14.52
14.62
pmol/l
0.38
416
3426
40
166
2.51
6.50
2.6
1.4
7.48
9.53
u/l
0.38
31
128
18
46
4.00
6.48
1.1
1.1
—
—
—
0
0
9
5
18.24
6.28
1.4
1.2
—
—
—
0
0
89
515
1.85
6.21
1.7
1.9
—
—
—
0
0
88
510
1.85
6.11
1.7
1.8
—
—
—
0
0
306
2456
1.50
5.60
6.6
6.1
9.55
11.59
umol/l
4.84
289
2327
112
721
1.68
5.39
3.6
3.8
0.83
0.81
mmol/l
0.56
106
680
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
15
30
5.10
5.28
1.1
1.1
—
—
—
0
0
426
3688
1.52
5.20
8.2
7.2
76.62
78.58
u/l
0.44
404
3461
227
1735
1.49
5.17
3.5
3.5
48.33
34.66
ng/l
0.44
155
1144
543
5005
1.82
4.86
17.7
12.8
23.33
22.02
mg/l
0.45
467
3903
36
174
2.14
4.20
1.3
1.4
—
—
—
0
0
229
1812
1.42
4.14
2.0
1.9
93.08
95.66
pmol/l
0.35
113
956
412
3621
1.43
4.03
4.7
4.0
10.69
11.14
mm/h
0.27
386
3341
90
596
1.60
3.85
6.1
5.7
1.05
1.04
mmol/l
0.13
79
550
197
1537
1.42
3.79
3.0
3.2
2.34
2.36
mmol/l
1.14
166
1375
16
56
2.91
3.65
2.1
1.3
0.71
0.50
nmol/l
0.67
16
50
10
21
4.82
3.57
1.6
1.0
—
—
—
0
0
16
57
2.86
3.55
2.2
2.2
—
—
—
0
0
244
1994
1.37
3.52
2.3
2.3
73.04
75.35
nmol/l
0.83
221
1790
8
13
6.22
3.51
1.1
1.3
—
—
—
0
0
6
6
10.08
3.50
1.3
1.2
2.35
7.68
nmol/l
—
6
6
10
22
4.60
3.44
1.3
1.2
—
—
—
0
0
211
1689
1.38
3.44
3.9
3.1
—
—
—
0
0
8
14
5.77
3.35
1.0
1.1
—
—
—
0
0
8
14
5.77
3.35
1.0
1.1
—
—
—
0
0
11
28
3.98
3.30
1.0
1.1
—
—
—
0
0
143
1081
1.42
3.23
5.1
3.5
1.02
1.02
kg/l
0.56
21
138
8
15
5.39
3.20
1.0
1.3
—
—
—
0
0
17
67
2.58
3.15
1.1
1.1
—
—
—
0
0
25
119
2.15
3.08
1.2
1.2
—
—
—
0
0
8
16
5.05
3.06
1.0
1.1
—
—
—
0
0
8
16
5.05
3.06
1.0
1.2
—
—
—
0
0
43
249
1.78
3.05
2.4
1.4
25.99
24.04
iu/l
0.13
37
205
557
5283
1.67
3.03
12.4
9.7
27.27
26.45
u/l
0.42
544
5099
493
4560
1.44
3.01
5.4
4.6
1.97
2.13
mu/l
0.22
457
4178
33
177
1.91
2.97
1.5
1.7
—
—
—
0
0
7
13
5.43
2.87
1.7
2.2
26.53
18.87
umol/l
—
7
13
287
2461
1.32
2.82
4.5
3.4
0.00
0.01
estimate
0.50
43
451
29
152
1.95
2.80
1.7
1.5
0.09
0.05
iu/ml
—
9
28
165
1317
1.35
2.64
5.1
3.7
0.00
0.01
estimate
0.88
42
467
30
164
1.87
2.58
2.7
1.8
1.73
3.63
ug/l
0.47
23
143
8
20
4.04
2.57
1.1
1.2
2.90
5.35
umol/l
—
8
20
107
799
1.41
2.57
1.9
1.7
1123.25
1181.05
nmol/l
0.31
86
610
5
7
7.19
2.55
1.0
1.6
—
—
—
0
0
55
361
1.58
2.48
3.1
2.4
7.04
6.39
ug/l
0.12
49
323
280
2429
1.28
2.40
5.8
4.6
0.00
0.00
estimate
-0.00
43
475
5
8
6.29
2.37
1.6
1.8
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
22
112
2.00
2.33
2.3
2.8
0.39
0.34
u/ml
—
9
61
48
311
1.59
2.30
1.8
1.5
—
—
—
0
0
104
790
1.38
2.26
3.5
2.6
1.48
0.92
e6/l
0.75
67
450
42
265
1.63
2.24
1.8
1.7
—
—
—
0
0
107
818
1.37
2.24
2.8
2.7
2.42
2.44
mmol/l
1.78
93
724
5
9
5.59
2.21
1.0
1.3
—
—
—
0
0
5
9
5.59
2.21
1.0
1.3
—
—
—
0
0
275
2398
1.27
2.21
7.1
5.9
57.45
56.61
%
0.55
259
2267
177
1462
1.30
2.19
2.8
2.4
55.71
59.30
u/l
0.41
160
1359
277
2420
1.27
2.18
4.6
3.4
0.00
0.00
estimate
0.50
46
496
277
2426
1.26
2.12
7.4
6.1
27.85
28.63
%
0.55
261
2294
76
555
1.42
2.08
4.4
4.2
31.71
31.96
%
0.08
59
366
32
192
1.70
2.07
1.7
1.9
—
—
—
0
0
127
1010
1.33
2.06
2.8
2.4
3.88
5.94
e6/l
1.19
115
905
17
83
2.08
2.03
1.3
1.2
4.27
4.11
u/ml
0.03
11
38
9
32
2.84
2.00
1.0
1.3
—
—
—
0
0
9
32
2.84
2.00
1.0
1.1
—
—
—
0
0
579
5614
1.70
2.00
27.0
18.8
4.50
4.53
e12/l
0.86
574
5468
7
21
3.36
1.97
1.0
1.0
1556.74
1374.33
miu/ml
—
7
21
131
1053
1.31
1.97
1.6
1.5
20.11
20.44
nmol/l
0.07
112
895
30
476
0.61
1.90
1.6
1.6
—
—
—
0
0
578
5609
1.66
1.88
27.6
18.9
40.24
40.41
%
0.34
546
5302
7
22
3.21
1.88
2.0
2.7
41185.71
34677.50
ug/l
—
7
22
7
22
3.21
1.88
1.0
1.0
—
—
—
0
0
145
1189
1.29
1.87
2.8
2.1
2.78
2.94
mg/l
0.42
122
1015
59
422
1.44
1.82
5.1
4.6
2.12
1.71
mmol/l
0.52
53
343
18
95
1.92
1.77
1.9
1.4
0.24
0.34
nmol/l
0.57
12
75
9
36
2.52
1.74
1.6
1.8
—
—
—
0
0
5
13
3.87
1.72
1.0
1.2
—
—
—
0
0
49
345
1.46
1.66
1.5
1.9
—
—
—
0
0
5
14
3.59
1.62
1.4
1.1
—
—
—
0
0
107
860
1.30
1.61
3.6
3.6
79.19
276.86
ng/l
2.39
74
627
15
77
1.97
1.60
1.1
1.1
—
—
—
0
0
364
3349
1.22
1.58
4.1
3.0
50.82
43.38
u/l
1.06
347
3157
8
33
2.44
1.54
3.8
2.8
—
—
—
0
0
45
319
1.44
1.49
3.3
3.9
0.68
1.68
mmol/l
1.12
34
230
27
173
1.59
1.42
1.6
2.1
—
—
—
0
0
21
126
1.69
1.42
1.4
1.7
—
—
—
0
0
189
1649
1.21
1.38
3.7
3.1
28.53
31.80
u/l
1.02
175
1581
154
1318
1.23
1.36
3.9
3.0
0.25
0.33
e6/l
0.36
126
999
11
54
2.06
1.33
1.5
1.8
—
—
—
0
0
168
1454
1.22
1.33
3.7
3.1
38.14
90.40
e6/l
0.56
141
1126
40
284
1.44
1.33
1.5
1.4
—
—
—
0
0
20
121
1.68
1.32
1.5
1.7
—
—
—
0
0
57
435
1.34
1.26
1.7
2.0
—
—
—
0
0
92
750
1.27
1.26
3.5
2.8
2.04
2.42
e6/l
0.24
56
414
16
92
1.76
1.26
1.4
1.7
—
—
—
0
0
142
1221
1.21
1.20
3.0
3.1
732.68
1121.61
ng/l
1.74
121
1041
483
4622
1.22
1.19
14.9
11.9
86.95
84.64
ml/min/173m2
1.30
416
3774
6
26
2.32
1.19
1.2
1.7
—
—
—
0
0
6
26
2.32
1.19
1.2
1.7
—
—
—
0
0
247
2236
1.18
1.17
3.1
2.7
103.93
105.34
ug/l
0.05
224
2075
18
112
1.63
1.10
1.4
1.2
—
—
—
0
0
12
66
1.83
1.09
1.0
1.3
—
—
—
0
0
48
366
1.34
1.09
2.1
2.6
70.86
69.57
ml/min/173m2
0.07
14
151
44
331
1.36
1.09
4.7
3.9
87.74
76.64
ng/l
0.30
36
297
25
169
1.50
1.09
1.8
1.3
—
—
—
0
0
13
75
1.75
1.03
1.5
1.6
—
—
—
0
0
14
83
1.70
1.02
2.2
2.6
18.17
15.78
%
—
7
41
15
91
1.66
1.01
1.0
2.2
143.33
128.88
g/l
—
9
66
9
48
1.89
1.00
6.1
3.1
1.68
6.80
nmol/l
—
9
48
11
61
1.82
0.99
1.2
1.6
—
—
—
0
0
44
338
1.33
0.97
1.8
3.0
68.39
67.01
g/l
0.55
38
305
137
1200
1.18
0.95
2.5
2.8
329.07
6713.15
umol/l
4.63
122
1058
14
85
1.66
0.95
1.3
1.7
—
—
—
0
0
17
109
1.58
0.94
1.2
1.2
—
11.89
—
0
7
108
929
1.20
0.92
1.6
1.7
439.70
6410693.64
pmol/l
0.50
94
780
6
29
2.08
0.89
1.3
1.8
—
—
—
0
0
10
56
1.80
0.88
1.2
1.7
—
—
—
0
0
210
1914
1.15
0.87
4.9
3.4
—
—
—
0
0
20
136
1.49
0.87
1.2
1.2
—
2.75
—
0
16
23
320
0.71
0.86
1.4
1.5
—
—
—
0
0
8
44
1.83
0.86
1.0
1.1
—
—
—
0
0
8
44
1.83
0.86
1.0
1.1
—
—
—
0
0
101
870
1.19
0.85
1.2
1.3
36.69
31.84
iu/ml
0.09
28
279
13
80
1.64
0.85
1.1
1.1
—
—
—
0
0
6
31
1.94
0.84
1.7
1.6
—
—
—
0
0
8
45
1.79
0.84
1.0
1.1
—
—
—
0
0
8
45
1.79
0.84
1.0
1.1
—
—
—
0
0
8
45
1.79
0.84
1.0
1.1
—
—
—
0
0
53
431
1.25
0.79
3.3
2.5
0.23
0.22
g/l
0.31
47
406
11
66
1.68
0.79
1.4
1.7
—
—
—
0
0
11
67
1.65
0.75
1.2
1.7
—
—
—
0
0
20
141
1.43
0.75
1.2
1.1
—
—
—
0
0
7
38
1.85
0.73
4.0
2.4
0.21
0.19
e9/l
—
7
32
7
38
1.85
0.73
4.7
2.3
—
—
—
0
0
20
142
1.42
0.73
1.3
1.3
—
—
—
0
0
46
372
1.26
0.73
1.1
1.2
166.31
176.23
iu/ml
0.05
19
160
5
25
2.01
0.73
1.4
1.8
—
—
—
0
0
7
39
1.80
0.72
4.0
2.4
686.29
531.94
e6/l
—
7
32
12
76
1.59
0.72
1.3
1.7
—
—
—
0
0
28
212
1.34
0.71
4.5
3.8
0.68
0.65
%
0.18
28
212
22
160
1.39
0.71
1.3
2.8
—
—
—
0
0
5
26
1.93
0.70
1.4
1.8
—
—
—
0
0
7
42
1.67
0.68
1.4
1.1
—
79.00
—
0
6
121
1082
1.15
0.66
2.0
1.8
1.40
1.19
mg/l
0.29
93
824
13
188
0.68
0.63
1.2
1.5
—
—
—
0
0
12
174
0.68
0.60
2.2
1.6
—
—
—
0
0
15
106
1.43
0.58
1.1
1.3
—
—
—
0
0
9
60
1.51
0.54
1.8
1.4
—
—
—
0
0
6
38
1.58
0.54
1.0
1.1
—
—
—
0
0
82
727
1.15
0.52
3.0
2.2
13.30
13.48
umol/l
0.08
73
679
6
40
1.50
0.51
2.0
2.3
—
—
—
0
0
15
109
1.39
0.51
1.1
1.7
—
—
—
0
0
158
1463
1.11
0.50
4.3
3.2
7.97
7.80
mmol/l
0.17
138
1255
32
262
1.23
0.49
2.1
2.6
0.25
0.15
e6/l
0.54
32
253
7
45
1.56
0.49
12.4
2.9
29.30
51.62
u/ml
—
7
45
73
646
1.15
0.49
1.9
1.8
1.56
1.45
%
0.53
67
577
147
1361
1.11
0.47
4.8
4.8
3.94
2.31
ug/l
0.62
131
1216
24
191
1.27
0.47
1.4
1.4
179.00
252.03
miu/ml
—
10
94
362
3493
1.09
0.47
3.2
3.3
—
—
—
0
0
7
48
1.46
0.47
1.1
1.2
—
—
—
0
0
13
176
0.73
0.46
1.2
1.4
—
—
—
0
0
13
176
0.73
0.46
1.2
1.4
—
—
—
0
0
13
176
0.73
0.46
1.2
1.4
—
—
—
0
0
13
176
0.73
0.46
1.2
1.4
—
—
—
0
0
37
314
1.19
0.42
2.8
3.1
168.48
170.64
ng/l
0.01
31
276
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
0
16
0.00
0.41
0.0
1.5
—
—
—
0
0
0
16
0.00
0.41
0.0
1.1
—
2.39
—
0
10
0
16
0.00
0.41
0.0
1.1
—
91.38
—
0
16
0
17
0.00
0.40
0.0
1.3
—
—
—
0
0
20
159
1.27
0.40
8.8
5.3
1.19
1.41
mg/l
1.42
20
146
7
103
0.68
0.40
1.0
1.5
—
—
—
0
0
5
35
1.43
0.39
1.2
1.9
—
—
—
0
0
479
4696
1.10
0.39
4.8
4.2
5.71
5.88
mmol/l
3.37
437
4295
5
36
1.39
0.38
1.2
1.3
2387.20
185000.80
e6/l
—
5
25
12
89
1.36
0.38
3.6
3.2
4.00
4.23
e9/l
0.16
12
89
8
115
0.69
0.37
1.5
1.5
—
—
—
0
0
16
202
0.79
0.37
1.3
1.9
—
—
—
0
0
85
780
1.10
0.34
1.9
2.2
—
—
—
0
0
12
91
1.33
0.34
1.3
1.6
—
—
—
0
0
12
91
1.33
0.34
1.3
1.6
—
—
—
0
0
10
133
0.75
0.34
1.2
1.7
—
—
—
0
0
116
1084
1.09
0.32
4.6
4.3
22.41
21.09
%
0.51
66
494
12
92
1.31
0.32
3.9
3.6
58.42
56.70
%
0.16
12
92
14
175
0.80
0.31
3.6
3.2
101.79
1707.02
u/ml
0.93
14
150
12
153
0.78
0.31
1.3
1.5
—
—
—
0
0
16
129
1.25
0.30
2.1
1.8
2.30
6.74
iu/l
—
7
40
7
54
1.30
0.30
1.3
1.5
—
—
—
0
0
7
54
1.30
0.30
1.3
1.5
—
—
—
0
0
7
54
1.30
0.30
1.3
1.5
—
—
—
0
0
18
149
1.21
0.28
2.1
1.8
36.33
38.63
nmol/l
0.19
18
143
8
64
1.25
0.27
1.5
1.6
—
—
—
0
0
8
64
1.25
0.27
1.5
1.6
—
—
—
0
0
8
64
1.25
0.27
1.0
1.3
—
—
—
0
0
8
66
1.21
0.27
1.0
1.3
—
—
—
0
0
8
66
1.21
0.27
1.0
1.3
—
—
—
0
0
12
95
1.27
0.26
2.1
1.8
—
—
—
0
0
90
841
1.08
0.26
1.3
1.3
4.21
11.76
u/ml
1.31
36
330
68
628
1.09
0.26
3.4
2.2
21.08
23.11
%
0.67
57
551
77
718
1.08
0.24
1.8
2.1
—
—
—
0
0
15
124
1.21
0.24
1.1
1.3
—
—
—
0
0
446
4391
1.06
0.24
20.5
15.6
14.86
14.59
%
0.42
446
4326
17
200
0.85
0.23
1.4
1.8
2.73
3.43
mg/l
—
9
154
11
88
1.25
0.22
1.2
1.3
—
—
—
0
0
11
88
1.25
0.22
1.2
1.3
—
—
—
0
0
17
144
1.19
0.22
1.6
1.6
—
—
—
0
0
5
42
1.19
0.21
1.0
1.1
—
—
—
0
0
142
1361
1.06
0.21
4.0
3.9
6.21
9.67
mg/mmol
0.58
97
870
0
13
0.00
0.21
0.0
1.4
—
8.39
—
0
8
0
13
0.00
0.21
0.0
1.0
—
25.11
—
0
13
15
128
1.18
0.18
1.1
1.3
—
—
—
0
0
126
1211
1.05
0.17
1.4
1.3
0.99
2.10
u/ml
1.02
31
318
80
842
0.94
0.17
1.3
1.4
—
—
—
0
0
83
790
1.06
0.16
2.7
2.9
0.80
0.75
ug/l
0.17
54
499
11
92
1.20
0.16
2.2
1.6
—
—
—
0
0
41
441
0.92
0.15
3.8
2.4
32.12
30.86
u/l
0.07
34
373
9
81
1.11
0.15
1.3
1.5
—
—
—
0
0
436
4407
0.96
0.14
5.8
5.4
38.25
39.48
mmol/mol
2.60
404
4109
17
150
1.14
0.14
1.2
1.1
—
—
—
0
0
13
113
1.15
0.13
2.2
1.9
177.38
230.27
pmol/l
0.79
13
103
15
168
0.89
0.12
1.3
1.4
—
—
—
0
0
17
153
1.11
0.11
1.2
1.1
—
—
—
0
0
5
44
1.14
0.10
1.0
1.0
—
—
—
0
0
45
428
1.06
0.10
3.4
4.3
4.44
34.28
ug/l
0.93
36
347
70
676
1.04
0.09
3.2
2.2
2.34
2.37
g/l
0.19
62
626
6
57
1.05
0.08
1.0
1.0
—
—
—
0
0
478
4808
0.97
0.08
4.5
4.2
4.71
4.67
mmol/l
0.39
453
4478
5
65
0.77
0.08
3.6
2.4
105.60
105.72
mmol/l
—
5
65
10
88
1.14
0.08
1.1
1.3
—
—
—
0
0
7
65
1.08
0.08
1.0
1.4
—
—
—
0
0
7
66
1.06
0.08
1.0
1.3
—
—
—
0
0
7
66
1.06
0.08
1.0
1.3
—
—
—
0
0
460
4627
0.98
0.07
4.0
3.7
1.25
1.28
mmol/l
0.63
430
4270
6
75
0.80
0.07
1.0
1.4
6.93
7.15
mmol/l
—
6
61
111
1089
1.02
0.06
1.5
1.6
—
—
—
0
0
127
1289
0.98
0.05
1.7
1.7
1.45
1.38
mmol/l
0.38
112
1092
53
544
0.97
0.04
3.2
2.8
8.48
8.48
umol/l
0.00
41
480
14
150
0.93
0.04
1.1
1.1
—
11.09
—
0
18
13
121
1.08
0.03
1.3
1.2
—
—
—
0
0
28
289
0.97
0.02
1.0
1.0
—
—
—
0
0
477
4782
0.99
0.02
4.5
4.1
1.49
1.47
mmol/l
0.59
447
4430
15
144
1.04
0.00
2.6
2.6
—
—
—
0
0
29
284
1.02
0.00
1.3
1.3
—
—
—
0
0
13
133
0.98
0.00
1.5
1.4
300.29
307.92
ug/g
—
7
74
46
465
0.99
0.00
4.0
3.2
—
—
—
0
0
488
4883
1.00
0.00
5.0
4.6
2.78
2.78
mmol/l
0.03
456
4526
18
181
0.99
0.00
1.6
1.7
—
—
—
0
0
22
219
1.00
0.00
1.4
1.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
0
9
0.00
0.00
0.0
1.7
—
1.21
—
0
9
0
8
0.00
-0.00
0.0
1.1
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
—
—
0
0
5
53
0.94
-0.00
1.0
1.3
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.0
—
52.40
—
0
5
5
56
0.89
-0.00
1.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
0.60
—
0
5
9
89
1.01
-0.00
1.1
1.1
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint CD2_BENIGN_BRAIN_SUPRATENT and mortality.
Females
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_BRAIN_SUPRATENT | 1.794 [1.53, 2.1] | < 0.001 |
| Birth year | 1.003 [1.0, 1.01] | 0.441 |
During the follow-up period (1.1.1998 — 31.12.2019), 355 out of 1970 females with CD2_BENIGN_BRAIN_SUPRATENT died.
Males
| Parameter | HR [95% CI] | p-value |
|---|---|---|
| CD2_BENIGN_BRAIN_SUPRATENT | 2.162 [1.81, 2.59] | < 0.001 |
| Birth year | 0.992 [0.98, 1.0] | 0.09 |
During the follow-up period (1.1.1998 — 31.12.2019), 363 out of 1653 males with CD2_BENIGN_BRAIN_SUPRATENT died.
Mortality risk
Mortality risk for people of age
years, who have CD2_BENIGN_BRAIN_SUPRATENT.| N-year risk | Females | Males |
|---|---|---|
| 1 | 0.206% | 0.378% |
| 5 | 1.309% | 2.719% |
| 10 | 2.936% | 7.058% |
| 15 | 5.921% | 13.53% |
| 20 | 11.166% | 22.667% |
Relationships between endpoints
↥Index endpoint: CD2_BENIGN_BRAIN_SUPRATENT – Benign neoplasm: Brain, supratentorial
GWS hits: -
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data